These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 25052517)
1. Chronic hepatitis B virus in young adults: the need for new approaches to management. Gill US; Kennedy PT Expert Rev Anti Infect Ther; 2014 Sep; 12(9):1045-53. PubMed ID: 25052517 [TBL] [Abstract][Full Text] [Related]
2. Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues. Boni C; Laccabue D; Lampertico P; Giuberti T; Viganò M; Schivazappa S; Alfieri A; Pesci M; Gaeta GB; Brancaccio G; Colombo M; Missale G; Ferrari C Gastroenterology; 2012 Oct; 143(4):963-73.e9. PubMed ID: 22796241 [TBL] [Abstract][Full Text] [Related]
3. Emerging pipeline drugs for hepatitis B infection. Cox N; Tillmann H Expert Opin Emerg Drugs; 2011 Dec; 16(4):713-29. PubMed ID: 22195605 [TBL] [Abstract][Full Text] [Related]
4. Treatment of chronic hepatitis B virus infection - Dutch national guidelines. Buster EH; van Erpecum KJ; Schalm SW; Zaaijer HL; Brouwer JT; Gelderblom HC; de Knegt RJ; Minke Bakker C; Reesink HW; Janssen HL; Neth J Med; 2008; 66(7):292-306. PubMed ID: 18663260 [TBL] [Abstract][Full Text] [Related]
5. Current issues and future directions in treatment. Hui CK; Lau GK Semin Liver Dis; 2006 May; 26(2):192-7. PubMed ID: 16673297 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus DNA and hepatitis B surface antigen levels in chronic hepatitis B. Fung J; Lai CL; Yuen MF Expert Rev Anti Infect Ther; 2010 Jun; 8(6):717-26. PubMed ID: 20521898 [TBL] [Abstract][Full Text] [Related]
8. Novel targets for hepatitis B virus therapy. Testoni B; Durantel D; Zoulim F Liver Int; 2017 Jan; 37 Suppl 1():33-39. PubMed ID: 28052622 [TBL] [Abstract][Full Text] [Related]
9. Toward a Functional Cure for Hepatitis B. Lok ASF Gut Liver; 2024 Jul; 18(4):593-601. PubMed ID: 38533651 [TBL] [Abstract][Full Text] [Related]
10. Natural history of chronic hepatitis B virus infection and long-term outcome under treatment. Liaw YF Liver Int; 2009 Jan; 29 Suppl 1():100-7. PubMed ID: 19207972 [TBL] [Abstract][Full Text] [Related]
11. Upcoming pharmacological developments in chronic hepatitis B: can we glimpse a cure on the horizon? Alonso S; Guerra AR; Carreira L; Ferrer JÁ; Gutiérrez ML; Fernandez-Rodriguez CM BMC Gastroenterol; 2017 Dec; 17(1):168. PubMed ID: 29268704 [TBL] [Abstract][Full Text] [Related]
12. Treatment of HBeAg-positive chronic hepatitis B with nucleos(t)ide analogues. Leung N Liver Int; 2011 Jan; 31 Suppl 1():85-9. PubMed ID: 21205143 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus-specific T-cell responses during IFN administration in a small cohort of chronic hepatitis B patients under nucleos(t)ide analogue treatment. Sprinzl MF; Russo C; Kittner J; Allgayer S; Grambihler A; Bartsch B; Weinmann A; Galle PR; Schuchmann M; Protzer U; Bauer T J Viral Hepat; 2014; 21(9):633-41. PubMed ID: 24251783 [TBL] [Abstract][Full Text] [Related]
14. Nucleos(t)ide analogues for hepatitis B virus: strategies for long-term success. Chien RN; Liaw YF Best Pract Res Clin Gastroenterol; 2008; 22(6):1081-92. PubMed ID: 19187868 [TBL] [Abstract][Full Text] [Related]
15. Effects of tenofovir disoproxil fumarate in hepatitis B e antigen-positive patients with normal levels of alanine aminotransferase and high levels of hepatitis B virus DNA. Chan HL; Chan CK; Hui AJ; Chan S; Poordad F; Chang TT; Mathurin P; Flaherty JF; Lin L; Corsa A; Gaggar A; Subramanian GM; McHutchison JG; Lau G; Lee S; Gane EJ Gastroenterology; 2014 May; 146(5):1240-8. PubMed ID: 24462735 [TBL] [Abstract][Full Text] [Related]
16. Antiviral therapy for chronic hepatitis B. Jafri SM; Lok AS Clin Liver Dis; 2010 Aug; 14(3):425-38. PubMed ID: 20638023 [TBL] [Abstract][Full Text] [Related]
18. Chronic hepatitis B: who to treat and which choice of treatment? Di Marco V; Craxì A Expert Rev Anti Infect Ther; 2009 Apr; 7(3):281-91. PubMed ID: 19344242 [TBL] [Abstract][Full Text] [Related]
19. Impact of therapy on the long-term outcome of chronic hepatitis B. Liaw YF Clin Liver Dis; 2013 Aug; 17(3):413-23. PubMed ID: 23905813 [TBL] [Abstract][Full Text] [Related]
20. [Clinical characteristics and effect of secondary individualized therapy in chronic hepatitis B patients infected with the rtA181 mutation hepatitis B virus]. Ji FZ; Wang L; Yang BH; Zhao JJ; Liu F; Xue Y; Li T Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):280-4. PubMed ID: 22964149 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]